Ingredion has announced a recommended all-cash acquisition of Tate & Lyle in a deal that sets the total enterprise value at approximately $5 billion (£3.7 billion), marking one of the largest ingredient industry transactions in recent years and significantly reshaping the global specialty ingredients landscape.
Under the agreement, Tate & Lyle shareholders will receive 595 pence per share, representing a roughly 59% premium to the company's May 13, 2026 closing price. The deal has unanimous support from both companies' boards and is expected to close in the second half of 2027, subject to shareholder, court, and regulatory approvals.
The acquisition combines two major players in specialty food ingredients, strengthening Ingredion's capabilities in texture, sugar reduction, sweetening, mouthfeel, and fortification. The combined company will operate across a broader global footprint spanning the Americas, Europe, the Middle East, Africa, and Asia-Pacific, creating a larger platform to serve food and beverage manufacturers seeking healthier, more functional, and affordable products.
Ingredion expects the transaction to generate approximately $130 million in annual cost synergies by 2030 and to be accretive to adjusted earnings per share within the first year after closing.
The deal underscores the growing value of specialty ingredient technologies as food manufacturers face increasing demand for sugar reduction, nutrition enhancement, clean-label formulations, and systems-based ingredient solutions. By adding Tate & Lyle's expertise in fortification and sweetening to its existing portfolio, Ingredion is positioning itself as a more comprehensive partner for global food and beverage innovation.
"This compelling combination will create exciting new possibilities for employees and generate significant value for all stakeholders," said Ingredion chairman, president and CEO Jim Zallie.
